YOU want to gain in efficiency in your screening

Relevant models are crucial for multi-target and multicellular diseases (e.g. cancer and neurodegenerative diseases).

WE believe in phenotypic screening as the answer

Because phenotypic screening is a global approach on cells and is performed by High Content Screening (HCS)

HCS Pharma is YOUR partner to implement HCS in your drug discovery

According to your needs, we support you or do it for you!

Services

Explain us your requirements and we develop your assays to best meet your needs !

More
Le site du projet CHOPIN est en ligne

Team

Want to know who we are ?

More
Le site du projet CHOPIN est en ligne

Why HCS ?

To target complex diseases (as cancer and neurodegenerative diseases), more than one target are needed and screening on complex model is recommended.

More
Le site du projet CHOPIN est en ligne

Contact Us

A question ? A comment ? Feel free to contact us !

More
Le site du projet CHOPIN est en ligne

Our Services

Latest Post

+francais

24th Apr 2017

More

Le site du projet CHOPIN est en ligne

Découvrez l'actualité de ce projet en ligne

+english

20th Apr 2017

More

Promissing encounters at in-cosmetics Global London

How cellular imaging and image analysis can be used !

+english

18th Apr 2017

More

Great conference on DYRK1A and related kinases and human disease !

We were in Saint Malo for the first meeting on DYRKs related disease

+english

13th Apr 2017

More

Precision Medicine, the good way to cure complexe diseases

Precision medicine is a new step in healthcare

+english

11th Apr 2017

More

It’s done, our laboratories in Lille Metropole are under construction !

Work began in our future laboratories

+english

10th Apr 2017

More

Meet us at « High-Content and Phenotypic Screening » in Cambridge

We will talk about advantages of 3D culture in phenotypic screening

+english

07th Apr 2017

More

Our vision of the future of laboratories at Forum LABO 2017 Paris

Deep Learning, Augmented and Virtual Realities could change the laboratory

+english

03rd Apr 2017

More

HCS Pharma at in-cosmetics Global in London

Julian, our COO, will attend in-cosmetics Global in London

+english

31st Mar 2017

More

Poster – In vitro dermocosmetology : high content analysis approach using human primary keratinocytes and fibroblasts

Our poster

+francais

30th Mar 2017

More

Création du label « France HealthTech »

France eHealthTech est un label du ministère français des affaires étrangères

+english

28th Mar 2017

More

DNA typos might be the main cause of genetic mutations occurs in cancer

A controversial study about links between tumors and genetic mutations

+english

20th Mar 2017

More

Elrigfr congres at ForumLabo : We will talk about the future of laboratories !

We will talk about the future of laboratories

+english

16th Mar 2017

More

How phenotypic screening could help to predict DILI ?

HCS/HCA is a great way to predict drugs toxicity

Hemarina relève 8 millions d’euros pour préserver les greffons

HEMO2life en voie de commercialisation

+english

16th Mar 2017

More

Meet us at the first DYRK conference in Saint Malo, march 28th to April 1st

The conference will focus on DYRK1A, DYRK1B, 2, 3, 4 and the closely related CLKs

+english

13th Mar 2017

More

We are hiring laboratory technicians

You want to join our teams in Rennes and in Lille ?

+english

10th Mar 2017

More

Phenotypic characterization on liver spheroïds

3D cell models are now attracting a huge interest from scientists working both on toxicity and pharmacology assay development....

+english

02nd Mar 2017

More

We are hiring a study director in Rennes !

Study Director position opens in Rennes

+english

02nd Mar 2017

More

We are hiring a business developer in Lille !

A position in open is Lille !

+english

27th Feb 2017

More

Comparing high content screening results

High Content - Less Mess, More Mesh